#BadPharma | Reviews of Bad Pharma in Books| Hashreview

#BadPharma

Bad Pharma: How Drug Companies Mislead Doctors and Harm Patients is a book by British physician and academic Ben Goldacre about the pharmaceutical industry, its relationship with the medical profession, and the extent to which it controls academic Read More..

by Ben Goldacre

Ratings

Likes

Reviews

HASH INFO

Review# tag	BadPharma
Review# tag
Hash title	Bad Pharma
Hash title
Description	Bad Pharma: How Drug Companies Mislead Doctors and Harm Patients is a book by British physician and academic Ben Goldacre about the pharmaceutical industry, its relationship with the medical profession, and the extent to which it controls academic research into its own products.Luisa Dillner, "Bad Pharma by Ben Goldacre – review", The Guardian, 17 October 2012. The book was published in September 2012 in the UK by the Fourth Estate imprint of HarperCollins, and in February 2013 in the United States by Faber and Faber.Goldacre argues in the book that "the whole edifice of medicine is broken" because the evidence on which it is based is systematically distorted by the pharmaceutical industry."He writes that the industry finances most of the clinical trials into its own products and much of doctors' continuing education, that clinical trials are often conducted on small groups of unrepresentative subjects and negative data is routinely withheld, and that apparently independent academic papers may be planned and even ghostwritten by pharmaceutical companies or their contractors, without disclosure.Bad Pharma, pp. x–xi, 287ff; "Pick your pill out of a hat", The Economist, 29 September 2012. Goldacre calls the situation a "murderous disaster," and makes suggestions for action by patients' groups, physicians, academics and the industry itself.Responding to the book's publication, the Association of the British Pharmaceutical Industry issued a statement arguing that the examples the book offers are historical, that the concerns have been addressed, that the industry is among the most regulated in the world, and that it discloses all data in accordance with international standards. "ABPI statement on Ben Goldacre's book 'Bad Pharma'", Association of the British Pharmaceutical Industry, 5 October 2012.Ben Adams, "Goldacre takes ABPI to task over book snub", Pharma Times, 12 October 2012.In January 2013 Goldacre joined the Cochrane Collaboration, British Medical Journal and others in setting up AllTrials, a campaign calling for the results of all past and current clinical trials to be reported. "About", alltrials.net; Tracey Brown, "It's time for AllTrials registered and reported", The Cochrane Library, 30 April 2013. The British House of Commons Public Accounts Committee expressed concern in January 2014 that drug companies were still only publishing around 50 percent of clinical-trial results.David Tovey, "Why the Public Accounts Committee Report on Tamiflu Is Important for Us All", Huffington Post, 3 January 2014.Rajeev Syal, "Drug companies accused of holding back complete information on clinical trials", The Guardian, 3 January 2014.
Description	Bad Pharma: How Drug Companies Mislead Doctors and Harm Patients is a book by British physician and academic Ben Goldacre about the pharmaceutical industry, its relationship with the medical profession, and the extent to which it controls academic research into its own products.Luisa Dillner, "Bad Pharma by Ben Goldacre – review", The Guardian, 17 October 2012. The book was published in September 2012 in the UK by the Fourth Estate imprint of HarperCollins, and in February 2013 in the United States by Faber and Faber.Goldacre argues in the book that "the whole edifice of medicine is broken" because the evidence on which it is based is systematically distorted by the pharmaceutical industry."He writes that the industry finances most of the clinical trials into its own products and much of doctors' continuing education, that clinical trials are often conducted on small groups of unrepresentative subjects and negative data is routinely withheld, and that apparently independent academic papers may be planned and even ghostwritten by pharmaceutical companies or their contractors, without disclosure.Bad Pharma, pp. x–xi, 287ff; "Pick your pill out of a hat", The Economist, 29 September 2012. Goldacre calls the situation a "murderous disaster," and makes suggestions for action by patients' groups, physicians, academics and the industry itself.Responding to the book's publication, the Association of the British Pharmaceutical Industry issued a statement arguing that the examples the book offers are historical, that the concerns have been addressed, that the industry is among the most regulated in the world, and that it discloses all data in accordance with international standards. "ABPI statement on Ben Goldacre's book 'Bad Pharma'", Association of the British Pharmaceutical Industry, 5 October 2012.Ben Adams, "Goldacre takes ABPI to task over book snub", Pharma Times, 12 October 2012.In January 2013 Goldacre joined the Cochrane Collaboration, British Medical Journal and others in setting up AllTrials, a campaign calling for the results of all past and current clinical trials to be reported. "About", alltrials.net; Tracey Brown, "It's time for AllTrials registered and reported", The Cochrane Library, 30 April 2013. The British House of Commons Public Accounts Committee expressed concern in January 2014 that drug companies were still only publishing around 50 percent of clinical-trial results.David Tovey, "Why the Public Accounts Committee Report on Tamiflu Is Important for Us All", Huffington Post, 3 January 2014.Rajeev Syal, "Drug companies accused of holding back complete information on clinical trials", The Guardian, 3 January 2014.

Created By

Admin

DETAILS

Name	Bad Pharma
Name
Authors	Ben Goldacre
Authors
Translator
Translator
Genre	Science writing , medicine , investigative journalism
Genre
Series
Series
Number in series
Number in series
Language
Language
Country
Country

PUBLISH

Story timeline
Story timeline
Pages	430 (first edition)
Pages
Media_type
Media_type
Isbn	978-0-00-735074-2
Isbn
Oclc
Oclc
Publisher	Fourth Estate (UK)
Publisher

RELEASE

Pub_date	25 September 2012
Pub_date
Release_date
Release_date

Writing

Style of narration

Portraying the concept

Language & literature

Castings & characters

Overall rating

MORE INFO

Ratings

No ratings yet.

Feature Ratings

No Feature ratings yet.

Popularity

Reaches

No data available now.

Ranks

This #hashtag is not ranked yet.